Assignee profile:

Trizell Ltd.

City:

Chinnor

Country:

United Kingdom

Published Applications:

16

Last publication date:

2024-08-08

Patent Grants:

11

Last grant date:

2025-08-19

Top Inventors for applications by Trizell Ltd.

These are the the leading inventors for applications assigned to Trizell Ltd.:

Recent patent applications by Trizell Ltd.

Trizell Ltd. based in Chinnor, GB has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-08-08 ✅ Patent 12,391,911 granted on 2025-08-19
US20240263125A1
Chemistry; metallurgy

Adherent Cell Culture Substrate Sampling Device

#2 | 2022-03-17 ✅ Patent 12,264,324 granted on 2025-04-01
US20220081696A1
Chemistry; metallurgy

Viral vector assay and vector

#3 | 2020-11-12 ✅ Patent 11,446,249 granted on 2022-09-20
US20200352862A1
Human necessities

Viral vector stabilization

#4 | 2020-11-12 ✅ Patent 11,547,668 granted on 2023-01-10
US20200352861A1
Human necessities

Viral vector stabilization

#5 | 2020-07-16
US20200222477A1
Human necessities

Method to Curtail the Progression of Non-Muscle Invasive Bladder Cancer To Muscle-Invasive Cancer

#6 | 2020-06-04 ✅ Patent 11,932,843 granted on 2024-03-19
US20200172847A1
Chemistry; metallurgy

Adherent cell culture substrate sampling device

#7 | 2020-05-28 ✅ Patent 11,781,102 granted on 2023-10-10
US20200165557A1
Chemistry; metallurgy

Large-scale PEI-mediated plasmid transfection

#8 | 2020-03-05 ✅ Patent 10,829,785 granted on 2020-11-10
US20200071725A1
Chemistry; metallurgy

Nucleic acid application primers

#9 | 2019-11-07 ✅ Patent 11,104,915 granted on 2021-08-31
US20190338307A1
Chemistry; metallurgy

Viral vector assay and vector

#10 | 2019-09-26 ✅ Patent 12,152,281 granted on 2024-11-26
US20190292609A1
Chemistry; metallurgy

Gene therapy vector contamination assay

#11 | 2019-09-12
US20190276846A1
Chemistry; metallurgy

Seeding An Adherent Cell Bioreactor With Non-Adherent Cells Increases Seeding Density Limit And Reduces Required Expansion Time

#12 | 2019-09-12
US20190275106A1
Human necessities

Anti-Angiogenic Gene Therapy Kit

#13 | 2019-07-18 ✅ Patent 11,242,504 granted on 2022-02-08
US20190218495A1
Chemistry; metallurgy

Aseptic bioreactor sampling system

#14 | 2019-01-31 ✅ Patent 11,261,416 granted on 2022-03-01
US20190031998A1
Chemistry; metallurgy

Fixed-bed bioreactor with constant-flow pump / tubing system

#15 | 2017-02-23
US20170051309A1
Chemistry; metallurgy

Seeding An Adherent Cell Bioreactor With Non-Adherent Cells Increases Seeding Density Limit And Reduces Required Expansion Time

#16 | 2017-01-26
US20170021039A1
Human necessities

Cancer Therapy

Also check out Trizell Ltd.'s (Chinnor, United Kingdom) applicant profile with 13 patent applications submitted.

AssigneeID:

118307 ⎘